Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting

Vishal Sharmaa Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaCorrespondence[email protected]

https://orcid.org/0000-0003-2472-3409 View further author information

Jayendra Shuklaa Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

https://orcid.org/0000-0003-0566-7376 View further author information

Vikas Surib Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaView further author information

Anuraag Jenaa Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

https://orcid.org/0000-0001-9074-6698 View further author information

Anirudh Mukerjeea Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaView further author information

Harshal S Mandavdhareb Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

https://orcid.org/0000-0001-8020-9848 View further author information

Ashish Bhallab Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaView further author information

Usha Duttaa Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

https://orcid.org/0000-0002-9435-3557 View further author information

show all

References

Anikhindi, S. A., and A. Kumar. Arora A. COVID-19 in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2020 Dec;14(12):1187–1193.
PubMed Web of Science ®Google Scholar
Kennedy NA, Jones GR, Lamb CA, et al. British society of gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2020 Jun;69(6):984–990.
PubMed Web of Science ®Google Scholar
Rubin DT, Feuerstein JD, Wang AY, et al. AGA Clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary. Gastroenterology. 2020 Jul;159(1):350–357.
PubMed Web of Science ®Google Scholar
Singh, A. K., A. Jena, P. Kumar-M, V. Sharma, and S. Sebastian. Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis. United Eur Gastroenterol J. 2020 Nov 19. 2050640620972602 doi: https://doi.org/10.1177/2050640620972602. Epub ahead of print. PMID: 33210980.
Google Scholar
Jena A, Singh AK, Kumar-M P, et al. Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: correct information is crucial. Dig Liver Dis. 2020. DOI:https://doi.org/10.1016/j.dld.2020.09.012.
Google Scholar
Board of Governors. Telemedicine practice guidelines. Enabling registered medical practitioners to provide healthcare using telemedicine. [ cited 22 September 2020]. https://www.mohfw.gov.in/pdf/Telemedicine.pdf
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date